A multicenter, open label, randomized, balanced, two treatment, three period, three sequence, reference replicate crossover, single dose, bioequivalence study of Capecitabine Tablets, USP 500mg manufactured by Amneal Pharmaceuticals, USA and XELODA® (Capecitabine) Tablets 500mg distributed by Genentech USA, Inc., A Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080-4990, following a single oral 2000mg (4x500mg) dose administration in adult human cancer patients under fed condition.
100 Clinical Results associated with Amneal Pharmaceuticals Pty Ltd.
Login to view more data
0 Patents (Medical) associated with Amneal Pharmaceuticals Pty Ltd.
Login to view more data
2
Literatures (Medical) associated with Amneal Pharmaceuticals Pty Ltd.
03 May 2022·Neurology
A Phase 3 Trial of IPX203 vs CD-LD IR in Parkinson’s Disease Patients with Motor Fluctuations (RISE-PD) (S16.010)
Author: LeWitt, Peter ; Stocchi, Fabrizio ; Ellenbogen, Aaron ; Espay, Alberto J. ; Isaacson, Stuart ; Hauser, Robert A. ; Pahwa, Rajesh ; D’Souza, Richard ; Visser, Hester
03 May 2022·Neurology
Duration of Benefit Per Dose: Post Hoc Analysis of “Good On” Time Per Dose for IPX203 vs CD-LD IR in the RISE-PD Phase 3 Trial (P10-11.002)
Author: Fisher, Stanley ; Fernandez, Hubert H. ; Banisadr, Ghazal ; Patel, Neepa ; Criswell, Susan ; Klos, Kevin ; Hauser, Robert A.
100 Deals associated with Amneal Pharmaceuticals Pty Ltd.
Login to view more data
100 Translational Medicine associated with Amneal Pharmaceuticals Pty Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.